2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cancer Treatment
In the realm of cancer research, innovative treatments are continually emerging, offering hope and progress in the fight against this formidable disease. From targeted therapies that pinpoint specific genetic mutations driving cancer growth to immunotherapies harnessing the body's immune system to combat tumors, the landscape of cancer treatment is rapidly evolving. Precision medicine, fueled by advancements in genomics and personalized diagnostics, enables tailored approaches that consider individual genetic profiles and tumor characteristics. Additionally, emerging modalities like CAR-T cell therapy show promising results in certain cancers, offering new avenues for treatment. Collaborative efforts among researchers, clinicians, and pharmaceutical companies drive the development of novel therapies, bringing us closer to more effective and less invasive cancer treatments. As research continues to unravel the complexities of cancer biology, the outlook for patients grows increasingly hopeful.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China